Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP944685.RAlWV6Ruzc35mj1fy24g4izF341QLiq9XjwHnmvweXerI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP944685.RAlWV6Ruzc35mj1fy24g4izF341QLiq9XjwHnmvweXerI130_assertion type Assertion NP944685.RAlWV6Ruzc35mj1fy24g4izF341QLiq9XjwHnmvweXerI130_head.
- NP944685.RAlWV6Ruzc35mj1fy24g4izF341QLiq9XjwHnmvweXerI130_assertion description "[Ecallantide is a potent and specific plasma kallikrein inhibitor approved for the treatment of acute attacks of HAE affecting any anatomic site.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP944685.RAlWV6Ruzc35mj1fy24g4izF341QLiq9XjwHnmvweXerI130_provenance.
- NP944685.RAlWV6Ruzc35mj1fy24g4izF341QLiq9XjwHnmvweXerI130_assertion evidence source_evidence_literature NP944685.RAlWV6Ruzc35mj1fy24g4izF341QLiq9XjwHnmvweXerI130_provenance.
- NP944685.RAlWV6Ruzc35mj1fy24g4izF341QLiq9XjwHnmvweXerI130_assertion SIO_000772 22149337 NP944685.RAlWV6Ruzc35mj1fy24g4izF341QLiq9XjwHnmvweXerI130_provenance.
- NP944685.RAlWV6Ruzc35mj1fy24g4izF341QLiq9XjwHnmvweXerI130_assertion wasDerivedFrom befree-2016 NP944685.RAlWV6Ruzc35mj1fy24g4izF341QLiq9XjwHnmvweXerI130_provenance.
- NP944685.RAlWV6Ruzc35mj1fy24g4izF341QLiq9XjwHnmvweXerI130_assertion wasGeneratedBy ECO_0000203 NP944685.RAlWV6Ruzc35mj1fy24g4izF341QLiq9XjwHnmvweXerI130_provenance.